New York A02443 amends the insurance law to clarify coverage requirements for epinephrine auto-injectors, allowing coverage to be subject to the.
New York A02443 amends the insurance law to require health insurance plans to cover epinephrine auto-injectors for emergency treatment of life-threatening allergic reactions. The coverage may be subject to the plan's annual deductible, except for preventive care services. The bill also caps the out-of-pocket cost for these devices at $100 annually, regardless of the insured's deductible or other cost-sharing requirements. This change aims to ensure that individuals with severe allergies have access to necessary medical devices while managing insurance costs.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.